Multipeptide immune response to cancer vaccine IMA901 after single-dose cyclophosphamide associates with longer patient survival
Steffen Walter(Universität Ulm), Harpreet Singh‐Jasuja(Immatics Biotechnologies (Germany))
Cited by 781
Related Papers
Cancer classification using the Immunoscore: a worldwide task force
|Journal of Translational Medicine|2012|803